Item 1.01 Entry into a Material Definitive Agreement. On August 14, 2026, Vuzix Corporation (the “Company”), entered into an Open Market Sales Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”) with respect to an at the market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.001 per sh…
Filed Aug 14, 2026Accepted Aug 14, 2026, 4:10 PM EDTCIK 1463972Accession 0001104659-26-097141
Vuzix is a leading designer, manufacturer and marketer of AI-powered smart glasses, waveguides and augmented reality technologies, components and products for the enterprise, medical, defense, security, and consumer markets. The Company’s products include head-mounted smart personal displays and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality, as well as OEM waveguide optical components and display engines. Vuzix holds more than 500 patents and patents pending and numerous IP licenses in the fields of optics, head-mounted displays, and augmented reality. The Company has won over 20 Consumer Electronics Show (or CES) awards for innovation since 2005 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in: Rochester, NY; and Kyoto and Okayama, Japan. For more information, visit the Vuzix website, X and Facebook pages.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 1.01Item 1.01 - Entry into Material Agreement
Item
1.01
Entry into a Material Definitive Agreement.
On
August 14, 2026, Vuzix Corporation (the “Company”), entered into an Open Market Sales
Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”) with respect to an at the market
offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par
value $0.001 per share (the “Common Shares”), subject to certain
conditions, through Jefferies as sales agent. This Sales Agreement replaces the prior Sales Agreement entered into between Jefferies
and the Company on February 9, 2024, and no sales will be made pursuant to the Prior Sales Agreement. The
issuance and sale, if any, of the Common Shares by the Company under the Sales Agreement will be made pursuant to the Company’s
effective registration statement on Form S-3 (File No. 333-276997) (the “Registration Statement”) and the prospectus supplement
dated August 14, 2026, and filed with the U.S. Securities and Exchange Commission (the “SEC”) pursuant to Rule 424(b) under
the Securities Act of 1933, as amended (the “Securities Act”), which relates to the sale of Common Shares having an aggregate offering price of up to $100,000,000.
Pursuant
to the Sales Agreement, the Company will notify Jefferies of the number of Common Shares to be issued, the dates on which such sales are
anticipated to be made, any limitation on the number of shares to be sold in any one day and any minimum price below which sales may not
be made Jefferies may sell the Common Shares by any method permitted by law deemed to be an “at the market offering”
as defined in Rule 415(a)(4) of the Securities Act of 1933, as amended. Jefferies will use its commercially reasonable efforts to place
the Common Shares from time to time, based upon such instructions from the Company. The obligations of Jefferies under the Sales Agreement
to sell the Common Shares are subject to a number of conditions that we must meet.
The Company will pay Jefferies a commission equal
to 3.0% of the aggregate gross proceeds we receive from the sale of the Common Shares. In addition, the Company has agreed
to reimburse Jefferies for certain expenses incurred in connection with the Sales Agreement and has provided Jefferies with customary
indemnification rights.
The offering of Common Shares pursuant to the Sales
Agreement will terminate upon the earlier of (i) the sale of all shares of our common stock subject to the Sales Agreement; and (ii) the
termination of the Sales Agreement as permitted therein. The Sales Agreement contains representations for the benefit of the Company and
Jefferies and other terms customary for similar agreements.
The foregoing description of the Sales Agreement
is not complete and is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is filed herewith
as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. A copy of the opinion of Sichenzia
Ross Ference Carmel LLP relating to the legality of the issuance and sale of the Common Shares in the offering is attached as Exhibit 5.1
hereto.
This Current Report on Form 8-K shall not
constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation,
or sale of the securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or other jurisdiction.
Item 9.01 Financial Statements
and Exhibits.
(d) Exhibits.
Exhibit Description
No.
─────────────────────────────────────────────────────────────────────────
1.1 Open Market Sale AgreementSM, dated as of
August 14, 2026, between the Company and Jefferies LLC.
5.1 Opinion of Sichenzia Ross Ference Carmel LLP
23.1 Consent of Sichenzia Ross Ference Carmel LLP (included
in Exhibit 5.1 above).
104 Cover Page Interactive Data File (embedded within Inline
XBRL document).